Related Experiment Video
Updated: May 8, 2026

Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
Published on: January 6, 2012
[Interest of selective progesterone receptor modulators in endometriosis]
P Merviel1, E Lourdel, S Sanguin
1Centre de gynécologie-obstétrique, centre d'AMP, CHU d'Amiens, 124, rue Camille-Desmoulins, 80054 Amiens cedex 1, France. Merviel.Philippe@chu-amiens.fr
Abstract:
The SPRM (selective progesterone receptor modulators) are agonists and/or antagonists of progesterone receptor. They are responsible for anovulation, amenorrhea and a lower prostaglandin levels, which leads to an improvement in pain and regression of lesions in endometriosis. On the endometrium, a particular aspect, the progesterone receptor modulator-associated endometrial changes (PAEC), raises additional studies to verify its harmlessness. However, due to the lack of hypoestrogenism and metabolic effects with these drugs, it is very likely that the SPRM will in the near future an important place in the treatment of endometriosis.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists